
pmid: 22974643
This article reviews the various imaging modalities available for the evaluation of patients presenting with a potential stroke syndrome, specifically acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. It reviews the various computed tomography (CT) modalities, including noncontrast brain CT (NCCT), CT angiography, and CT perfusion. It discusses multimodal magnetic resonance imaging in the evaluation of patients with acute stroke, including diffusion-weighted imaging, T2-weighted sequences/fluid-attenuated inversion recovery, magnetic resonance angiography, perfusion-weighted imaging, and gradient-recalled echo. At the end of this article, a brief review on how to read an NCCT geared toward the emergency physician is included.
Brain, Neuroimaging, Subarachnoid Hemorrhage, Magnetic Resonance Imaging, Cerebral Angiography, Stroke, Diffusion Magnetic Resonance Imaging, Humans, Tomography, X-Ray Computed, Magnetic Resonance Angiography, Cerebral Hemorrhage
Brain, Neuroimaging, Subarachnoid Hemorrhage, Magnetic Resonance Imaging, Cerebral Angiography, Stroke, Diffusion Magnetic Resonance Imaging, Humans, Tomography, X-Ray Computed, Magnetic Resonance Angiography, Cerebral Hemorrhage
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
